Navigation Links
HealthWarehouse.com, Inc. Announces Completion of Business Combination With Clacendix, Inc.
Date:5/15/2009

Business combination should enable HealthWarehouse.com to accelerate expansion of industry-leading $3.50 prescription drug program

CINCINNATI, May 15 /PRNewswire-FirstCall/ -- HealthWarehouse.com, Inc., a privately held Delaware corporation, and Clacendix, Inc. (OTC Bulletin Board: IONN.OB) announced today the completion of their business combination pursuant to a securities exchange agreement. The combined company will assume and execute the HealthWarehouse.com business plan as its sole business. In connection with the business combination, Clacendix intends to change its name to HealthWarehouse.com. Until the name change becomes effective, Clacendix shares will continue to be quoted on the OTC Bulletin Board under the ticker IONN.OB.

Under the securities exchange agreement, Clacendix acquired all the outstanding capital stock of HealthWarehouse.com from the existing stockholders of HealthWarehouse.com in exchange for newly-issued shares of Clacendix common stock. As a result of the share exchange, HealthWarehouse.com is now a wholly-owned subsidiary of Clacendix and the former HealthWarehouse.com stockholders will own, on a post-transaction basis, approximately 82.4% of the outstanding common stock of Clacendix. Prior to the close of the business combination, HealthWarehouse.com completed a financing, raising net proceeds of $1.2 million from accredited investors. Clacendix will file a Form 8-K on or before May 20, 2009, which will contain detailed business and financial information concerning the combined company.

HealthWarehouse.com, a licensed U.S. online mail-order pharmacy, is working to revolutionize the way Americans purchase prescription drugs and healthcare products. In addition to offering cost savings, HealthWarehouse.com seeks to enhance the consumer experience by providing exceptional customer service, convenience and privacy. With some of the lowest priced prescriptions in the United States, 100% free shipping and 90-day returns with no restocking fees, consumers have responded by making HealthWarehouse.com one of the fastest growing online pharmacies.

Clacendix CEO, Norman Corn said, "We are truly excited, having searched for a suitable business combination candidate for over a year. HealthWarehouse.com is growing at an incredible rate with an impressive business model that we believe delivers outstanding consumer value."

Upon the close of the business combination, the company appointed Lalit Dhadphale as Chairman, President and CEO, in addition to his duties as a director of HealthWarehouse.com, he will now serve as director of the combined company. Patrick E. Delaney, Chief Financial Officer at Clacendix, will continue in the same role.

"This is a significant step forward for our company," states CEO Lalit Dhadphale. "We are excited to leverage the public financial markets to fund expansion and further accelerate our strategy to deliver consumers a convenient and affordable option when purchasing prescription drugs in the United States."

About HealthWarehouse.com

HealthWarehouse.com, Inc. is a licensed U.S. online mail-order pharmacy based in Cincinnati, Ohio. HealthWarehouse.com is the first company to offer FDA-approved generic prescriptions at $3.50 for 30-day supplies and $9.50 for 90-day supplies with 100% free shipping. HealthWarehouse.com's mission is to redefine the meaning of healthcare and relentlessly strive to make it affordable for all Americans.

The information contained in this press release contains "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. A forward-looking statement is one which is based on current expectations of future events or conditions and does not relate to historical or current facts. These statements include various estimates, forecasts, projections of Clacendix' future performance, statements of Clacendix' plans and objectives, and other similar statements. Forward-looking statements include phrases such as "expects," "anticipates," "intends," "plans," "believes," "predicts," "estimates," "assumes," "projects," "may," "will," "will be," "should," or similar expressions. Although Clacendix believes that its current expectations are based on reasonable assumptions, it cannot assure you that the expectations contained in such forward-looking statements will be achieved. Forward-looking statements involve risks, uncertainties and assumptions which could cause actual results to differ materially from those contained in such statements. Investors should not place undue reliance on the forward-looking statements contained in this press release, as they speak only as of the date of this press release, and Clacendix expressly disclaims any obligation or undertaking to publicly release any updates or revisions to any forward-looking statements contained herein.


'/>"/>
SOURCE HealthWarehouse.com, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Smith & Nephew Orthopaedics Announces First Contribution to OREF Grants Fund
2. Cigna Medical Group Announces Grand Opening of CareToday Clinic in Anthem, Ariz.
3. Americans United for Life Announces Legal Prospectus on Probable Supreme Court Nominees
4. Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results
5. Ontario Systems Announces New Alliance With Microsoft
6. Boston Scientific Announces Schedule for EuroPCR 2009
7. Exiqon Announces New Grant Program for MicroRNA Research
8. May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO
9. BioCryst Pharmaceuticals Announces Presentation of Forodesine Data at the 45th Annual Meeting of the American Society of Clinical Oncology
10. Standard & Poors Announces Changes to U.S. Index
11. WuXi PharmaTech Announces First-Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... Diego, California (PRWEB) , ... May 24, 2017 ... ... care through innovative medical image management and interpretation, has received U.S. Food and ... , Nucleus.io is a web-based, scalable and secure cloud platform for medical ...
(Date:5/24/2017)... ... , ... Patients who want to receive cosmetic dentistry procedures such as Invisalign® ... for a consultation, with or without a referral. Dr. Bedich enjoys improving the appearance ... , Dr. Bedich offers a variety of cosmetic dentistry services at his practice that ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... ... recently completed Course II of the HP3 (High-Performance Periodontal Practice) continuing education (CE) ... learning the latest advancements in his field by attending numerous CE courses each ...
(Date:5/24/2017)... ... May 24, 2017 , ... Accordant Technology, a trusted ... ExtraHop delivers an analytics-first approach, layered with machine learning, that provides real-time visibility ... to the cloud to the edge. Through the new partnership, customers get the ...
(Date:5/24/2017)... ... May 24, 2017 , ... Rob Lowe is a sought after actor, ... Television. “Informed” brings the public important topics from all aspects of life, and a ... and issues surrounding feet and ankles. , Podiatry is essential to people’s overall well-being, ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... 4, 2017  A new tight-tolerance microextrusion medical ... highly-engineered materials, is being launched by Natvar, a ... developed in recent years to service a wide ... applications. More expensive materials such as glass and ... due to their ability to consistently hold tolerances. ...
(Date:5/3/2017)... ROCKVILLE, Md. , May 3, 2017 /PRNewswire/ ... revenue growth of nine percent next year and ... solid organ and hematopoietic stem cell (HSCT) or ... and donor. Molecular testing technologies are well-suited for this ... healthcare-only market research publisher Kalorama Information. The various ...
(Date:5/2/2017)... and NEW YORK and ... As the leading distributor of market intelligence, MarketResearch.com is ... Med Tech Reimbursement Consulting AB that allows for ... Consulting AB,s proprietary market analyses through the MarketResearch.com website. ... the world easy access to complete product descriptions and ...
Breaking Medicine Technology: